Phase II Study of Abarelix Depot for Androgen Independent Prostate Cancer Progression During Gonadotropin-Releasing Hormone Agonist Therapy-Reference-Cited by-同舟云学术

Phase II Study of Abarelix Depot for Androgen Independent Prostate Cancer Progression During Gonadotropin-Releasing Hormone Agonist Therapy

Published:2003-05 Issue:5 Volume:169 Page:1738-1741
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

BEER TOMASZ M.¹,GARZOTTO MARK¹,EILERS KRISTI M.¹,LEMMON DIANNE¹

Affiliation:

1. From the Divisions of Hematology and Medical Oncology, Oregon Health & Science University and Division of Urology, Portland VA Medical Center, Portland, Oregon

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference20 articles.

1. Coexpression of gonadotropic hormones and their corresponding FSH- and LH/CG-receptors in the human prostate

2. HORMONE-REFRACTORY PROSTATE CANCER CELLS EXPRESS FUNCTIONAL FOLLICLE-STIMULATING HORMONE RECEPTOR (FSHR)

3. Prolactin and pituitary gonadotropin values and responses to acute luteinizing hormone-releasing hormone (LHRH) challenge in patients having long-term treatment with a depot lhrh analogue

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Asymmetric biomimetic transamination of α-keto amides to peptides;Nature Communications;2021-08-30

2. Switching from a GnRH agonist to a GnRH antagonist in prostate cancer patients: A systematic review and meta-analysis;Canadian Urological Association Journal;2019-05-13

3. Efficacy of degarelix in prostate cancer patients following failure on luteinizing hormone-releasing hormone agonist treatment: results from an open-label, multicentre, uncontrolled, phase II trial (CS27);Therapeutic Advances in Urology;2015-03-04

4. Luteinizing hormone-releasing hormone (LHRH) receptor agonists vs antagonists: a matter of the receptors?;BJU International;2013-02-18

5. New considerations for ADT in advanced prostate cancer and the emerging role of GnRH antagonists;Prostate Cancer and Prostatic Diseases;2012-07-03